This $674 Million Deal Aims To Turn Your Bodys Garbage Disposal Into A Disease Fighter
VantAI has inked a partnership with pharma giant Bristol Myers Squibb that hopes to use the body’s cellular waste disposal…
41,920€
0,44%
Echtzeit-Aktienkurs Bristol-Myers Squibb Co.
Bid:
Ask:
Nachrichten zur Bristol-Myers Squibb Co. Aktie
How This Top 2% Biotech Overcame Two Obstacles And Doubled
Cytokinetics is looking to take on Bristol Myers Squibb in treating a heart disease.…
Senators to question Merck, J&J and Bristol Myers Squibb CEOs over high U.S. drug pricing
The push to cut drug prices is one of those rare hot-button issues that unites the two major political parties.…
Redburn cuts Bristol-Myers Squibb price target to $54 By Investing.com
Redburn cuts Bristol-Myers Squibb price target to $54…
FDA to review expanded use of Bristol Myers Squibbs Abecma By Investing.com
FDA to review expanded use of Bristol Myers Squibbs Abecma…
Bristol-Myers Squibb: All Focus On Execution
…
Bristol-Myers Squibb: Massive Discount Spells Opportunity
…
Bristol Myers Squibb (BMY) Q4 2023 Earnings Call Transcript
BMY earnings call for the period ending December 31, 2023.…
Bristol-Myers Squibb Company 2023 Q4 - Results - Earnings Call Presentation
…
Bristol-Myers Squibb Company (BMY) Q4 2023 Earnings Call Transcript
…
Bristol Meyers Squibb, AbbVie top 4Q sales and profit estimates
Drugmakers Bristol-Myers Squibb Co (NYSE:BMY, ETR:RM, OTC:BMYMP) and Abbvie Inc (NYSE:ABBV) on Friday both reported better than expected financial results...…
Stocks making the biggest premarket moves: Meta, Amazon, Bristol-Myers Squibb, Chevron and more
These are the stocks posting the largest moves in the premarket.…
Bristol-Myers Squibb beats in Q4 as Eliquis and Opdivo outperform
…
Bristol-Myers Squibb tops Q4 expectations, reports strong anemia drug sales By Investing.com
Bristol-Myers Squibb tops Q4 expectations, reports strong anemia drug sales…
Bristol-Myers Squibb earnings beat by $0.10, revenue topped estimates By Investing.com
Bristol-Myers Squibb earnings beat by $0.10, revenue topped estimates…
Bristol Myers Squibb results top expectations as newer drugs help fuel growth
Bristol Myers Squibb on Friday reported fourth-quarter results that beat analysts’ expectations, helped by portfolio stalwarts as well as newer…
Bristol Myers Squibb results top estimates as new drugs post strong sales growth
Bristol Myers Squibb also issued its full-year 2024 forecast, which was generally in line with expectations.…
Antibiotics Market revenue to surpass USD 108 Billion by 2035, says Research Nester
Major antibiotics market players include F.Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, Teva Pharmaceuticals Industries Ltd., Pfizer Inc., Abbott Laboratories, Merck…
Bayer und Eli Lilly: Heißer Markt
Der Markt für Radiopharmaka bleibt für große Player von Interesse. Das haben die jüngsten Übernahmen von Rayzebio (durch Bristol Myers…
Healthy Returns: J&J, Merck and Bristol Myers Squibb are in the hot seat
J&J, Merck and Bristol Myers Squibb face a pivotal few weeks ahead. Meanwhile, Apple will reportedly explore health applications for…
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
The CEOs of Merck, Johnson & Johnson and Bristol Myers Squibb will testify at the hearing on drug prices, Sen.…
Bristol-Myers Squibb: Dont Waver Over Undue Fears And Doubts
…
Is Bristol Myers Squibb Stock a Buy Now?
This healthcare stock has seen healthier days.…
Melanoma Drugs - $13.98 Billion Industry Opportunity Assessment, 2024-2028: Regional Insights and Competitor Market Shares
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Melanoma Drugs Global Market Report 2024" report has been added…
Bristol Myers Squibb: Might Be Approaching A Bottom In 2024
…
Biotech Market Forecast: Top Trends That Will Affect Biotech in 2024
The biotech sector is a dynamic and constantly evolving industry that is driving scientific advancements and innovation in healthcare. According…
A Rare And Major Dividend Stock Buying Opportunity With Altria And Bristol Myers Squibb
…
Bristol-Myers Squibb: Big Dividend Yield, Unloved Big-Pharma Deal
…
NHWK: Transformational Changes
By John Vandermosten, CFA
NYSE:NHWK
NightHawk Biosciences, Inc. (NYSE:NHWK) reported 3Q:23 results on November 20th, 2023 as published in a press release…
AstraZeneca: Rebound in 2024 With Double-Digit Earnings Growth
Stocks Analysis by MarketBeat.com (Kate Stalter) covering: Eli Lilly and Company, Merck & Company Inc, Pfizer Inc, Bristol-Myers Squibb Company.…
Bristol-Myers Squibb: I Went Looking For Value And Found A 4.63% Yield Also
…
Bile Duct Cancer Treatment Market Trends and Forecast 2031 - Market Set for Significant Growth by 2031 Amid Rising Incidences and Technological Advancements
Dublin, Jan. 09, 2024 (GLOBE NEWSWIRE) -- The "Bile Duct Cancer Treatment Market - Global Industry Analysis, Size,…
Bristol-Myers CEO talks new acquisitions: We are writing the next chapter of this company
Bristol-Myers Squibb CEO Chris Boerner detailed the pharmaceutical giants slew of recent acquisitions in a Monday interview with CNBCs Jim…
Bristol-Myers Squibb Company (BMY) J.P. Morgan 42nd Annual Healthcare Conference (Transcript)
…
PRTG: Bridging I-O: Working in Harmony with Checkpoints
By John Vandermosten, CFA
NASDAQ:PRTG
READ THE FULL PRTG RESEARCH REPORT
We are initiating coverage of Portage Biotech Inc. (NASDAQ:PRTG) with a target…
Evotec: Neue Meilensteinzahlung treibt Aktie an
Trotz des kürzlichen CEO-Wechsels zeigt die Evotec-Aktie Anzeichen einer Erholung. Unterstützend wirkt dabei eine Meilensteinzahlung von Bristol-Myers Squibb.…
Evotec auf Erholungskurs: BMS-Deal zahlt sich aus
Die Aktie von Evotec befindet sich nach dem Einbruch von vergangener Woche wieder auf Erholungskurs. Das Papier gewinnt am Vormittag…
ROUNDUP: Evotec erhält Meilensteinzahlung aus Partnerschaft mit BMS - Kursplus
HAMBURG (dpa-AFX) - Die Zusammenarbeit des Wirkstoffforschers und -entwicklers Evotec mit dem US-Pharmakonzern Bristol Myers Squibb (BMS) trägt…
ANALYSE-FLASH: RBC belässt Evotec auf Sector Perform - Ziel 18,60 Euro
NEW YORK (dpa-AFX Broker) - Die kanadische Bank RBC hat Evotec auf "Sector Perform" mit einem Kursziel von 18,60…
EVOTEC SE Sector Perform
NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat Evotec auf "Sector Perform" mit einem Kursziel von 18,60 Euro…
Evotec erhält Meilensteinzahlung aus Partnerschaft mit Bristol Myers Squibb
HAMBURG (dpa-AFX) - Die Zusammenarbeit des Wirkstoffforschers und -entwicklers Evotec mit dem US-Pharmakonzern Bristol Myers Squibb (BMS) trägt…
RBC belässt Evotec auf Sector Perform - Ziel 18,60 Euro
NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat Evotec auf "Sector Perform" mit einem Kursziel von 18,60 Euro…
EQS-News: Evotec SE: Evotec verkündet Fortschritt in strategischer Neurologie-Partnerschaft mit Bristol Myers Squibb
EQS-News: Evotec SE / Schlagwort(e): Sonstiges Evotec verkündet Fortschritt in strategischer Neurologie-Partnerschaft mit Bristol Myers Squibb 08.01.2024 / 07:30 CET/CEST…
EQS-News: Evotec verkündet Fortschritt in strategischer Neurologie-Partnerschaft mit Bristol Myers Squibb (deutsch)
Evotec verkündet Fortschritt in strategischer Neurologie-Partnerschaft mit Bristol Myers Squibb ^ EQS-News: Evotec SE / Schlagwort(e): Sonstiges Evotec verkündet…
Novartis Buy
FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Novartis auf "Buy" mit einem Kursziel von 110 Franken…
dpa-AFX: Deutsche Bank belässt Novartis auf Buy - Ziel 110 Franken
FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für
Novartis auf "Buy" mit einem Kursziel von 110 Franken belassen.…
Deutsche Bank belässt Novartis auf Buy - Ziel 110 Franken
FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Novartis auf "Buy" mit einem Kursziel von 110 Franken…
Sosei Group Announces Appointment of Experienced Pharmaceutical Executive Toshihiro Maeda as Chief Operating Officer
Tokyo, Japan and Cambridge, UK, 5 January 2024 – Sosei Group Corporation (“Sosei Heptares” or “the Company”; TSE: 4565) today…
Bristol-Myers Squibb Company (BMY) Management presents at Goldman Sachs Healthcare C-Suite Unscripted Conference (Transcript)
…
Best Places to Work: Die 25 besten Arbeitsplätze in Europa für 2023 bekannt gegeben
Bad Marienberg (www.aktiencheck.de) - Die Organisation Best Places to Work hat heute die 25 besten Arbeitsplätze in Europa für 2023…